Logotipo de Valence
populares
Iniciar sesión
Loading data for DERM — first visit, this takes a few seconds.

Añadir a la lista de seguimiento

Journey Medical Corporati...

NasdaqCM: DERM · Precio en tiempo real · USD
6.46
-0.26 (-3.87%)
Al cierre: Aug 17, 2026, 8:00 PM
6.46
+0.00%
Fuera de horario: 7:30 PM

Journey Medical Corporation (DERM) Stock Price, Analysis & Data

-3.87%

No hay datos disponibles

Precio de compra4.76
Capitalización de mercado177.87M
Ingresos (TTM)64.68M
Beneficio neto (TTM)-9.59M
Beta1.08
EPS (TTM)-0.21
Ratio PER (TTM)n/a
Adelante PE-107.67
P/B (TTM)5.51
P/S (TTM)2.75
Earnings DateNov 11, 2026
Precio de venta8.35
Volumen287,622
Volumen medio (20D)256,918
Abierto6.73
Anterior Cerrar6.72
Rango del día6.45 - 6.81
Rango de 52 semanas4.31 - 9.55
analistan/a
Precio objetivon/a
Dividendosn/a
Fecha ex dividendon/a

Acerca de DERM

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topica...

[Leer más]
Industria Drug Manufacturers - Specialty & Generic
Sector Healthcare
IPO Fecha Nov 12, 2021
Empleados 58
Bolsa de Valores NasdaqCM
Símbolo bursátil DERM
Sitio web https://journeymedicalcorp.com
Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Journey Medical fueron 61.86M, un aumento de 10.2% en comparación con 56.13M del año anterior. Las ganancias fueron -11.43M, una disminución de -22.09%.

Estados financieros

Sorpresa de resultados

Journey Medical ha publicado sus resultados trimestrales en Aug 12, 2026:
  • Ingresos de $15.96M falla las estimaciones por $0, con 21.48% Crecimiento interanual.
  • EPS de -0.01 supera las estimaciones en 0.01, con 93.75% Crecimiento interanual.

    • Próxima publicación de resultados

    Está previsto que Journey Medical Corporation publique sus resultados el Nov 11, 2026, durante el horario de mercado.
    Los analistas proyectan ingresos de ... Actualizar
    news image

    6 días hace · GuruFocus.com

    Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ...

    Journey Medical Corp (DERM) narrows net loss to $300K as Emrosi prescriptions hit all-time highs and payer access expands.

    news image

    6 días hace · Moby

    Journey Medical Corporation Q2 2026 Earnings Call Summary

    Moby summary of Journey Medical Corporation's Q2 2026 earnings call

    news image

    6 días hace · MarketBeat

    Fortress Biotech Q2 Earnings Call Highlights

    Journey Medical reported higher second-quarter revenue and improved profitability, driven by continued prescription growth and improving payer reimbursement for its rosacea treatment Emrosi. Chief Exe...

    news image

    6 días hace · MarketBeat

    Journey Medical Q2 Earnings Call Highlights

    Journey Medical (NASDAQ:DERM) reported higher second-quarter revenue and a sharply narrower net loss as sales of its rosacea treatment EMROSI continued to grow, supported by rising prescription volume...

    news image

    6 días hace · Zacks

    Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings

    The headline numbers for Journey Medical (DERM) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street e...

    Página 1 de 2